Group sales rose 6% to 34.9 billion Swiss francs in the first nine months of the year due to strong demand for Roche's HER2 breast-cancer treatments. Now is the time to enter this wonderful field of pharmaceutical sales.
via Education - Latest News http://www.prlog.org/12229135-napsr-newsroche-posts-strong-sales-growth-in-the-first-nine-months-of-2013.html
via Education - Latest News http://www.prlog.org/12229135-napsr-newsroche-posts-strong-sales-growth-in-the-first-nine-months-of-2013.html
No comments:
Post a Comment